The management of atrial fibrillation in heart failure

被引：1

作者：

Bala R. ^{[1
]}

Callans D.J. ^{[1
]}

机构：

[1] Hospital of The University of Pennsylvania, Cardiovascular Division, Department of Electrophysiology, Philadelphia, PA 19104

来源：

Current Treatment Options in Cardiovascular Medicine | 2006年 / 8卷 / 4期

关键词：

Atrial Fibrillation; Right Ventricular; Amiodarone; Cardiac Resynchronization Therapy; Catheter Ablation;

D O I：

10.1007/s11936-006-0053-3

中图分类号：

学科分类号：

摘要：

The development of atrial fibrillation (AF) can greatly complicate the course of heart failure (HF). Although recent trials have indicated the nonsuperiority of a rhythm control strategy in the general population with AF, this may not apply to patients with HF. We feel strongly that AF be treated aggressively in patients with HF, defaulting toward an initial rhythm control strategy, to avoid the hemodynamic detriment of irregular rapid ventricular response and the development of tachycardia-related myopathy. The index episode is treated with cardioversion and antiarrhythmic therapy. If significant benefit is demonstrated, the rhythm control strategy is maintained, to the point of catheter ablation for AF if necessary. If there is no change in cardiac performance or symptoms after cardioversion, strict rate control is enforced, to the point of atrioventricular node ablation and pacing if necessary. Copyright © 2006 by Current Science Inc.

引用

页码：325 / 333

页数：8

共 36 条

[11]

Nattel S., Shiroshita A., Cardin S., Et al., Mechanisms for atrial remodeling and clinical relevance, Curr Opin Cardiol, 20, pp. 21-25, (2004)

[12]

Sanders P., Morton J.B., Davidson N.C., Et al., Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans, Circulation, 108, pp. 1461-1468, (2003)

[13]

Fenelon G., Wijns W., Andries E., Et al., Tachycardiomyopathy: Mechanisms and clinical implications, Pacing Clin Electrophysiol, 19, pp. 95-106, (1996)

[14]

Haissaguerre M., Jais P., Shah D.C., Et al., Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N Engl J Med, 339, pp. 659-666, (1998)

[15]

Hsu L.F., Jais P., Sanders P., Et al., Catheter ablation for atrial fibrillation in congestive heart failure, N Engl J Med, 351, pp. 2373-2383, (2004)

[16]

Chen M.S., Marrouche N.F., Khaykin Y., Et al., Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function, J Am Coll Cardiol, 43, pp. 1004-1009, (2004)

[17]

Fuster V., Ryden L.E., Asinger R.W., Et al., ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation), J Am Coll Cardiol, 38, pp. 1231-1265, (2001)

[18]

Naccarelli G.V., Hynes B.J., Wolbrette D.L., Et al., Atrial fibrillation in heart failure: Prognostic significance and management, J Cardiovasc Electrophysiol, 14, SUPPL., (2003)

[19]

Hohnloser S.H., Kuck K.H., Lilienthal J., Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial, Lancet, 356, pp. 1789-1794, (2000)

[20]

Van Gelder I.C., Hagens V.E., Bosker H.A., Et al., A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, 347, pp. 1834-1840, (2002)

← 1 2 3 4 →